BioSmart Co.,Ltd. (KOSDAQ:038460)
South Korea · Delayed Price · Currency is KRW 3,125.00
-185.00 (-5.59%)
At close: May 29, 2026
BioSmart Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 11,448 | 9,009 | 127.17 | 17,907 | 721.31 | 1,392 |
Depreciation & Amortization | 7,125 | 7,435 | 8,204 | 8,490 | 9,572 | 5,632 |
Loss (Gain) From Sale of Assets | -252.29 | -276.14 | 315.55 | -16,442 | -143.33 | 341.1 |
Asset Writedown & Restructuring Costs | 149.34 | 149.34 | 1,830 | 1,355 | 54.55 | 3,036 |
Loss (Gain) From Sale of Investments | -536.19 | -1,194 | -972.67 | 1,576 | 102.27 | -283.56 |
Loss (Gain) on Equity Investments | 1,215 | 1,359 | -2,228 | 20.7 | -321.76 | 3,042 |
Provision & Write-off of Bad Debts | 157.95 | 91.46 | -362.6 | 1,270 | 603.54 | 149.35 |
Other Operating Activities | 10,749 | 8,468 | 9,655 | 2,391 | 4,274 | 799.81 |
Change in Accounts Receivable | -10,267 | -3,041 | -4,707 | -1,719 | -1,146 | -4,534 |
Change in Inventory | -8,536 | -1,907 | 2,574 | -1,871 | -6,246 | -594.6 |
Change in Accounts Payable | 6,114 | 2,884 | 2,983 | -4,637 | 1,972 | -2,564 |
Change in Other Net Operating Assets | -2,634 | 1,095 | -13,708 | -7,176 | -3,138 | -5,203 |
Operating Cash Flow | 14,732 | 24,073 | 3,708 | 1,166 | 6,289 | 1,203 |
Operating Cash Flow Growth | 164.82% | 549.15% | 218.15% | -81.47% | 422.93% | - |
Capital Expenditures | -37,042 | -33,245 | -6,922 | -3,113 | -4,359 | -5,332 |
Sale of Property, Plant & Equipment | 344.46 | 239.28 | 108.4 | 811.84 | 191.4 | 1,946 |
Cash Acquisitions | - | - | - | - | - | -26,748 |
Divestitures | - | - | - | 24,646 | 4,000 | - |
Sale (Purchase) of Intangibles | -1,062 | -519.95 | -1,739 | -1,804 | -1,508 | -531.3 |
Investment in Securities | 12,295 | 14,420 | 6,558 | -29,642 | 872.1 | -1,151 |
Other Investing Activities | 1,785 | 2,049 | 365.97 | 213.78 | -1,195 | -0.03 |
Investing Cash Flow | -23,455 | -16,831 | -8,825 | -8,834 | -2,028 | -31,797 |
Short-Term Debt Issued | - | 67,537 | 107,860 | 168,750 | 117,567 | 58,755 |
Long-Term Debt Issued | - | 17,000 | 10,000 | 11,000 | 11,900 | 21,517 |
Total Debt Issued | 79,939 | 84,537 | 117,860 | 179,750 | 129,467 | 80,272 |
Short-Term Debt Repaid | - | -59,863 | -129,299 | -161,955 | -97,983 | -54,179 |
Long-Term Debt Repaid | - | -3,442 | -7,717 | -11,734 | -24,931 | -7,348 |
Total Debt Repaid | -60,795 | -63,304 | -137,016 | -173,690 | -122,914 | -61,527 |
Net Debt Issued (Repaid) | 19,144 | 21,233 | -19,157 | 6,060 | 6,553 | 18,746 |
Issuance of Common Stock | - | - | 7,996 | - | - | 5,850 |
Repurchase of Common Stock | -9.3 | -9.3 | - | - | - | - |
Dividends Paid | - | - | - | - | -360 | - |
Other Financing Activities | -10,918 | -10,898 | 5,946 | -150.04 | -3,686 | -0 |
Financing Cash Flow | 8,217 | 10,326 | -5,025 | 8,910 | 2,507 | 24,596 |
Foreign Exchange Rate Adjustments | 43.14 | 42.41 | 12.35 | -2.57 | -39.34 | 30.69 |
Miscellaneous Cash Flow Adjustments | 1,600 | 1,600 | 90.02 | -0 | -701.69 | 1,125 |
Net Cash Flow | 1,137 | 19,210 | -10,040 | 1,239 | 6,027 | -4,843 |
Free Cash Flow | -22,310 | -9,172 | -3,213 | -1,947 | 1,930 | -4,129 |
Free Cash Flow Margin | -4.32% | -1.90% | -0.66% | -0.43% | 0.49% | -2.18% |
Free Cash Flow Per Share | -881.90 | -362.89 | -151.61 | -76.57 | 100.52 | -215.07 |
Cash Interest Paid | 2,675 | 2,593 | 3,327 | 4,088 | 2,567 | 1,242 |
Cash Income Tax Paid | 3,231 | 3,899 | 8,963 | 2,924 | 2,616 | 1,280 |
Levered Free Cash Flow | -26,918 | -9,642 | -7,160 | 201.02 | 9,029 | -14,664 |
Unlevered Free Cash Flow | -25,145 | -7,856 | -4,261 | 3,927 | 11,777 | -13,389 |
Change in Working Capital | -15,323 | -969.51 | -12,859 | -15,403 | -8,574 | -12,907 |